0.5 mL. 1st dose: At elected date. 2nd dose: 2 mth after the 1st dose. 3rd dose: 6 mth after the 1st dose. If an alternate vaccination is necessary: 2nd dose: At least 1 mth after the 1st dose. 3rd dose: At least 3 mth after the 2nd dose. To be given IM in the deltoid region of the upper arm or in the higher anterolateral area of the thigh. Childn 9-13 yr 2 doses (1st dose: At elected date; 2nd dose: 6 mth or 12 mth) or 3 doses (1st dose: At elected date; 2nd dose: 2 mth after the 1st dose; 3rd dose: 6 mth after the 1st dose).
View Gardasil overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity. Individuals who develop symptoms indicative of hypersensitivity after receiving a dose of Gardasil should not receive further doses. Pregnancy.
Do not use for the treatment of active external genital lesions, cervical, vulvar, vag or anal cancers; CIN, VIN, VaIN or AIN. Individuals w/ impaired immune responsiveness due to immunosuppressive therapy, a genetic defect or HIV infection w/ thrombocytopenia or any coagulation disorder. Syncope may follow any vaccination, especially in adolescents. Appropriate medical treatment should be readily available in case anaphylactic reactions occur following administration of vaccine. Increase in headache & inj site swelling have been observed w/ concomitant administration w/ other vaccines. Inj at a separate inj site when administered concomitantly w/ other vaccines. Pregnancy.